Prophylactic antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus can be stopped at delivery

被引：14
|
作者：
Zeng, Q-L [1 ]
Xu, G-H [2 ]
Wang, B. [3 ]
Li, Z-Q [1 ]
Yu, Z-J [1 ]
机构：
[1] Zhengzhou Univ, Dept Infect Dis & Hepatol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Yanan Univ, Dept Infect Dis, Affiliated Hosp, Yanan, Peoples R China
[3] Tsinghua Univ, Dept Gynaecol & Obstet, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Beijing, Peoples R China
来源：
JOURNAL OF VIRAL HEPATITIS | 2018年 / 25卷 / 05期
关键词：
GUIDELINES;
D O I：
10.1111/jvh.12848
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 33 条
  • [1] Knowledge and awareness of perinatal antiviral use in the prevention of mother-to-child hepatitis B virus transmission among maternal chronic hepatitis carriers
    Low, Jia Ming
    Ma, Ting
    Lee, Guan-Huei
    Lee, Le Ye
    SINGAPORE MEDICAL JOURNAL, 2024, 65 (09) : 514 - 518
  • [2] Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa
    Wilson, Peyton
    Parr, Jonathan B.
    Jhaveri, Ravi
    Meshnick, Steve R.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (08) : 1180 - 1183
  • [3] Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus
    Zhang, C. -Y.
    Ahir, B. -K.
    Wu, G-B.
    Zhong, J. -H.
    Li, L. -Q.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (05) : 562 - 563
  • [4] Chinese Clinical Practice Guidelines for the Prevention and Treatment of Mother-to-Child Transmission of Hepatitis B Virus (Version 2024)
    Liu, Jinfeng
    Zeng, Qinglei
    Ji, Fanpu
    Ren, Hong
    Zhang, Wenhong
    Li, Lanjuan
    Zhao, Yingren
    INFECTIOUS MICROBES & DISEASES, 2024, 6 (03): : 108 - 116
  • [5] Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: Current standards of care
    Giles, Michelle L.
    Grace, Ruth
    Tai, Amy
    Michalak, Katarzyna
    Walker, Susan P.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2013, 53 (03) : 231 - 235
  • [6] Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
    Zhu, Bo
    Lv, Xiaojing
    Zhao, Zhiying
    Chen, Liwen
    Chen, Xiuli
    Li, Congjie
    Li, Suwen
    Dai, Erhei
    MEDICINE, 2021, 100 (44)
  • [7] Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis
    Yin, Juan
    Liang, Peifeng
    Chen, Gang
    Wang, Fuzhen
    Cui, Fuqiang
    Liang, Xiaofeng
    Zhuang, Guihua
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95 : 118 - 124
  • [8] Prevention of Mother-to-Child Human Immunodeficiency Virus Transmission in Resource-Limited Countries
    Knapp, Katherine M.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2022, 69 (01) : 1 - 18
  • [9] Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017
    Lolekha, Rangsima
    Chokephaibulkit, Kulkanya
    Phanuphak, Nittaya
    Chaithongwongwatthana, Surasith
    Kiertiburanakul, Sasisopin
    Chetchotisakd, Pleonchan
    Boonsuk, Sarawut
    ASIAN BIOMEDICINE, 2017, 11 (02) : 127 - 144
  • [10] Editorial: tenofovir alafenamide fumarate-a new silver bullet to prevent mother-to-child transmission of hepatitis B virus
    Gish, Robert G.
    Elmofti, Yousif
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (11-12) : 1744 - 1745
1234